MedPath

Effect of Assertiveness Training on Social Anxiety in a Virtual Reality Setting: A Pilot

Not Applicable
Conditions
Social Anxiety Disorder
Mental Health - Anxiety
Registration Number
ACTRN12619001154190
Lead Sponsor
ISN Psychology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
34
Inclusion Criteria

Participants with social anxiety will be recruited from the community using a number of inclusionary and exclusionary criteria. Participants must be aged 18 to 65. To ensure a fully immersive virtual reality experience, individuals will be required to self-identified as being proficient in English in order to comprehend the self-training module and dialogues, have normal or corrected to normal vision, as well as normal hearing.

In addition, a number of screening tools will be used to determine participant eligibility, details as follows:

Motion Sickness Screening
- The MSSQ-R will be used to screen out individuals susceptible to motion sickness or simulation sickness. Individuals scoring 13 and above will be excluded due to higher chance of experiencing simulation sickness.

Social Anxiety
- The LSAS-SR will be used to measure participants’ social anxiety, Rytwinski et al. (2009) indicated a cutoff score of 60 suggest the presence of social anxiety disorder. Therefore, individuals scoring below 60 will be excluded from the study.

Assertiveness
- In order to test the effectiveness of the assertiveness training module, individuals scoring 20 and above on the RAS will be excluded due to high levels of assertiveness or aggressiveness.

Exclusion Criteria

The virtual environment can elicit discomfort, which may potentially confound the results and create transient harm to potential participants. There is also a theoretical risk that VR will induce seizure. Therefore individuals with a history of epilepsy, seizures, motion sickness or simulation sickness will be excluded. The current study also excludes individuals receiving concurrent psychotherapy targeting unassertiveness due to the potential of confounding results.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath